Formula Growth’s Dillards DDS Stock Holding History

Formula Growth’s Portfolio DDS Stock Details DDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-127,937	Closed	-$12.4M	–	157
2021 Q1	$12.4M	Buy	+127,937	New	+$10.4M	1.78%	13

Other funds holding DDS

Newport Trust Company Washington, District of Columbia $40.7B AUM 24.62% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

PPA

Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Formula Growth's DDS Position: Q2 2021 in Review

Formula Growth sold out of Dillards (DDS) in Q2 2021, closing a stake of 127,937 shares — an estimated $12.4M sold.

Formula Growth first reported a position in DDS in Q1 2021 and held it in 1 quarter. The position peaked at $12.4M in Q1 2021. 156 funds tracked by Wall St. Rank hold DDS as of Q2 2021.

Formula Growth reported no remaining Dillards position as of Q2 2021 after selling out during the quarter.
Formula Growth sold 127,937 Dillards shares in Q2 2021, an estimated $12.4M.
Formula Growth first reported a position in Dillards in Q1 2021 and held it in 1 quarter.
Formula Growth's Dillards position peaked at $12.4M in Q1 2021.
156 funds tracked by Wall St. Rank held Dillards as of Q2 2021.

Based on Formula Growth's 13F filing for Q2 2021, filed 13 Aug 2021.